bpc 157 in women What is BPC-157? Potential Side Effects of BPC-157

Safety, Quality, and Compliance Regulatory status: BPC-157 is not FDA-approved for therapeutic use in humans

Given that the conceptual Robert and Szabos stomach/cytoprotection relation is translated to the protection of other tissues (Robert and Szabos organoprotection), BPC 157, as a peptidergic agent that is native and lacking degradation in the human gastric juice and is stable for more than 24 h, conceptually emerges as a novel cytoprotection mediator with particular cytoprotective capabilities, which are effectively translated into pleiotropic beneficial effects [2,3,4,5,6,7,8]

Hydroxocobalamin is another type of vitamin B12 injection

thus, resistant peptic ulcers equal to resistant chronic skin ulcers, both unable to heal (Skorjanec et al., 2009)